Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
U.S.A
B., & Onur, M
In phase II trials focusing on dermal applications, TB-500 has displayed promising outcomes for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa
Nat Rev Mol Cell Biol
Full and distended stomach, and vascular response P Sikiric 1 , S Seiwerth, L Brcic, A B Blagaic, I Zoricic, M Sever, R Klicek, B Radic, N Keller, K Sipos, A Jakir, M Udovicic, A Tonkic, N Kokic, B Turkovic, S Mise, T Anic ~ Int J Mol Sci
US$ 23.56
US$ 21.20
US$ 20.64
US$ 27.52
US$ 29.80
US$ 24.58
US$ 28.69
US$ 21.47
US$ 28.99
